These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21495223)

  • 1. Introduction: Should ovarian failure in survivors of childhood cancers be treated with hormonal therapy?
    Appelbaum H
    J Pediatr Adolesc Gynecol; 2011 Apr; 24(2):98. PubMed ID: 21495223
    [No Abstract]   [Full Text] [Related]  

  • 2. Part 1: Hormone replacement for survivors of childhood cancer with ovarian failure--when is it worth the risk?
    Fish JD
    J Pediatr Adolesc Gynecol; 2011 Apr; 24(2):98-101. PubMed ID: 21495224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and risks of hormone replacement therapy in young adult cancer survivors with gonadal failure.
    Mulder JE
    Med Pediatr Oncol; 1999 Jul; 33(1):46-52. PubMed ID: 10401497
    [No Abstract]   [Full Text] [Related]  

  • 4. Part 2: Ovarian failure in adolescent cancer survivors should be treated.
    Hershlag A; Rausch ME; Cohen M
    J Pediatr Adolesc Gynecol; 2011 Apr; 24(2):101-3. PubMed ID: 21495226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of hormone therapy for menopausal symptoms and quality of life in breast cancer survivors. Safe and ethical?
    Garrido Oyarzún MF; Castelo-Branco C
    Gynecol Endocrinol; 2017 Jan; 33(1):10-15. PubMed ID: 27898259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Disease Risk After Treatment-Induced Premature Ovarian Insufficiency in Female Survivors of Hodgkin Lymphoma.
    Krul IM; Opstal-van Winden AWJ; Janus CPM; Daniëls LA; Appelman Y; Maas AHEM; de Vries S; Jóźwiak K; Aleman BMP; van Leeuwen FE
    J Am Coll Cardiol; 2018 Dec; 72(25):3374-3375. PubMed ID: 30573037
    [No Abstract]   [Full Text] [Related]  

  • 7. Menarche in primary ovarian insufficiency after a month of hormone replacement therapy: a case report.
    Cheng B
    J Med Case Rep; 2021 Feb; 15(1):92. PubMed ID: 33618767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological sex steroid replacement in premature ovarian failure.
    Mahajan NN; Mahajan K
    Hum Reprod; 2012 Oct; 27(10):3119; author reply 3119-20. PubMed ID: 22811307
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormone replacement therapy regimens in chemotherapy-induced premature ovarian failure and the subsequent correction of hormone levels.
    Stangel-Wojcikiewicz K; Zdebik A; Jach R; Huras H; Wadowska-Jaszczynska K; Radon-Pokracka M; Kempisty-Zdebik E; Ludwin A; Ludwin I
    Neuro Endocrinol Lett; 2012; 33(7):697-702. PubMed ID: 23391877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailored hormonal approach in women with premature ovarian insufficiency.
    Fruzzetti F; Palla G; Gambacciani M; Simoncini T
    Climacteric; 2020 Feb; 23(1):3-8. PubMed ID: 31352836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stratford 2010 relived.
    Sturdee D
    Menopause Int; 2010 Sep; 16(3):98-9. PubMed ID: 20956682
    [No Abstract]   [Full Text] [Related]  

  • 12. Two successful pregnancies in a patient with chemotherapy-induced ovarian failure while on hormone replacement therapy.
    Ghazeeri G; Awwad J
    Gynecol Endocrinol; 2012 Apr; 28(4):286-7. PubMed ID: 22122545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer.
    Larsen EC; Müller J; Schmiegelow K; Rechnitzer C; Andersen AN
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5307-14. PubMed ID: 14602766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.
    Blumenfeld Z; Zur H; Dann EJ
    Oncologist; 2015 Nov; 20(11):1283-9. PubMed ID: 26463871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Premature ovarian insufficiency--a threat to a woman's health?].
    Oksjoki S; Jokimaa V
    Duodecim; 2015; 131(2):136-42. PubMed ID: 26237915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The British Menopause Society and Women's Health Concern recommendations on the management of women with premature ovarian insufficiency.
    Hamoda H;
    Post Reprod Health; 2017 Mar; 23(1):22-35. PubMed ID: 28381102
    [No Abstract]   [Full Text] [Related]  

  • 17. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy.
    Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR
    J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian benign clear cell adenofibroma in a patient with premature ovarian failure after 8-year hormone replacement therapy.
    Chen R; Zhou H; Zhang Y
    Gynecol Endocrinol; 2013 Mar; 29(3):216-8. PubMed ID: 23153077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis accompanied by premature ovarian failure and aggravation by estrogen.
    Li Y; Xiao B; Xiao L; Zhang N; Yang H
    Intern Med; 2010; 49(6):611-3. PubMed ID: 20228602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic fibroids in two patients on hormone replacement therapy with primary ovarian failure secondary to prepubertal gonadotoxic cancer treatment.
    Kalra SK; Gracia CR; Barnhart KT
    J Womens Health (Larchmt); 2008; 17(6):1035-7. PubMed ID: 18554096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.